Sinha Vikas

CIK 00013378454 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001337845

Recent Transactions

50 trades

Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-19$0.55/sh−3,186→ 1,140,894 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-05$0.86/sh−5,136→ 1,144,080 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-22$0.77/sh−1,882→ 1,149,216 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-21$0.78/sh−1,546→ 1,151,098 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-03$0.81/sh−940→ 1,152,644 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-19$0.76/sh−3,159→ 1,153,584 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-05$0.73/sh−5,251→ 1,156,743 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-22$0.74/sh−1,858→ 1,161,994 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-19$0.75/sh−1,542→ 1,163,852 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-02$0.72/sh−939→ 1,165,394 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-17$0.75/sh−3,143→ 1,129,996 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-03$0.80/sh−4,957→ 1,133,139 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2024-04-29+240,000→ 240,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-22$0.75/sh−1,857→ 1,138,096 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-19$0.75/sh−1,521→ 1,139,953 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-02$0.77/sh−885→ 1,141,474 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-20$0.70/sh−2,893→ 1,142,359 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-05$0.67/sh−18,331→ 1,145,252 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-23$0.67/sh−3,205→ 1,163,583 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-04$0.64/sh−961→ 1,166,788 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-11-17$1.63/sh−2,490→ 1,167,749 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-20$1.54/sh−1,475→ 1,170,239 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-19$1.58/sh−1,232→ 1,171,714 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-03$1.98/sh−755→ 1,172,946 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-08-17$2.50/sh−10,516→ 1,173,701 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-07-20$3.35/sh−1,437→ 1,184,217 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-07-19$3.56/sh−1,198→ 1,185,654 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-07-05$3.05/sh−2,983→ 1,186,852 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2023-04-28+96,000→ 96,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-04-20$3.63/sh−1,466→ 1,185,055 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-04-19$3.71/sh−1,217→ 1,186,521 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-02-02+157,500→ 1,187,738 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2023-02-02+292,500→ 1,012,362 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-01-20$5.14/sh−1,426→ 1,030,238 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-01-19$5.08/sh−5,111→ 1,031,664 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-20$9.36/sh−1,449→ 1,036,775 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-19$9.36/sh−1,449→ 1,036,775 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-16+100,000→ 1,038,224 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-28$4.61/sh+3,253,796→ 16,674,766 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-20$5.21/sh−1,432→ 938,224 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-07-01+54,600→ 54,600 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-01+29,400→ 939,656 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2022-04-28+200,000→ 200,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-04-20$6.68/sh−1,162→ 906,633 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-20$8.75/sh−6,450→ 858,957 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-18+48,838→ 907,795 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-01-18+119,162→ 119,162 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2021-08-09+64,000→ 64,000 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2021-05-04$0.84/sh−10,016→ 74,440 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2021-02-01$0.99/sh−10,224→ 84,456 total

Sinha Vikas

Recent Transactions

Companies

Recent Filings

Address